Adaptimmune Therapeutics ADAPY Growth Metrics (2015-2025)

OTC ADAPY
$0.02 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Adaptimmune Therapeutics Quarterly Growth Metrics

Periods 41 quarters
Latest Jun 2025

Adaptimmune Therapeutics reported revenue growth of 35.17% and asset growth of -30.45% for the quarter ended Jun 2025. These growth metrics cover 41 quarters of results from Jun 2015 through Jun 2025, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Growth Ratios
Total Debt (QoQ)
99.83%0.75%-49.42%1.04%
Total Debt Growth (1y)
2.89%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
25.00%-6.65%74.20%2.16%-7.89%-3.83%15.72%-9.68%-27.39%7.73%-57.53%128.94%-17.04%-3.33%0.81%-1.45%-0.10%-300.16%110.94%97.46%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
18.55%22.36%20.79%17.44%17.03%19.32%15.77%19.48%12.07%6.74%-18.54%-1.22%-4.67%-3.87%-2.27%-0.89%10.91%-34.43%-14.31%-12.83%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
16.55%2.44%4.52%10.13%7.48%8.79%17.10%16.44%26.26%15.55%4.99%13.50%-1.00%0.16%-16.53%-17.52%-15.26%-48.37%-50.71%-36.02%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
80.22%19.70%268.37%107.66%53.02%57.64%4.72%-7.41%-27.02%-18.25%-70.00%-23.94%-13.10%-22.02%85.08%-20.33%-4.05%-298.67%-78.43%-56.79%
Revenue (QoQ)
137.65%25.90%-71.11%613.13%-61.13%17.79%152.29%54.91%26.53%57.39%331.64%-89.22%42.67%-96.84%2,358.01%2,158.38%-68.10%-92.12%126.10%87.74%
Revenue Growth (5y)
-24.76%24.70%-31.69%56.66%-13.02%-30.17%4.59%9.48%-23.75%20.90%42.17%-10.71%-29.08%-31.02%282.31%180.15%34.65%57.11%93.67%
Revenue Growth (3y)
-64.73%-29.41%-62.45%-30.04%-69.10%-1.42%227.96%209.22%147.43%296.96%117.01%83.06%-46.42%135.63%246.03%223.96%31.50%26.78%35.17%
Revenue Growth (1y)
403.38%106.32%-42.97%516.53%0.84%-5.66%723.73%78.93%482.46%678.26%1,231.50%-7.37%4.45%-97.91%-88.07%2,399.63%458.83%1,294.81%28.30%-89.33%
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.30M0.05M-0.62M0.75M-0.22M0.05M0.16M0.06M0.02M0.04M0.03M-0.09M0.02M-2.09M2.07M0.09M-0.01M-0.22M0.17M0.04M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.28M-0.22M-0.82M0.57M-0.27M-0.29M-0.06M-0.01M-0.06M0.04M0.04M-0.06M-0.07M-1.94M-0.07M2.27M1.69M0.19M0.33M0.58M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.30M-0.18M-0.84M-0.10M-0.35M-0.09M-0.12M2.18M1.63M0.39M0.39M0.52M0.24M-1.91M0.79M0.13M0.35M0.07M0.08M0.06M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
1.39M0.17M-0.48M0.48M-0.05M-0.05M0.73M0.05M0.29M0.28M0.14M-0.01M0.00M-2.13M-0.09M0.09M0.06M1.93M0.02M-0.03M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
0.00M-0.02M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.00M-492.00-669.00-776.00-935.000.00M0.00M0.00M0.00M0.00M0.00M0.01M-218.00-0.01M-0.03M0.04M0.01M-0.01M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M0.00M0.00M0.00M0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.01M0.00M0.00M-0.01M-0.05M-0.01M0.00M-0.01M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-592.00-379.00-777.00145.000.00M0.00M0.00M-0.01M-0.01M-0.01M0.00M0.00M-0.01M-0.01M-0.05M-0.01M955.00-0.01M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.01M0.01M0.00M-802.000.00M0.00M0.00M-0.01M-0.01M-0.01M0.00M0.00M0.00M-891.00-0.04M0.00M0.00M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
883.00-391.00-406.00-654.00-555.0098.0043.00-805.00-694.00-58.000.00M-153.00-47.000.00M0.00M0.01M0.00M0.00M0.00M-0.01M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M0.00M0.00M0.00M-783.000.00M0.00M0.00M0.00M-479.00198.000.00M0.00M-0.01M455.000.01M0.01M0.00M-0.01M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
186.00586.00571.00746.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-0.01M483.000.00M0.00M284.00-0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.01M0.00M-568.000.00M0.00M0.00M0.00M0.00M0.00M18.00671.000.00M-282.000.00M0.00M0.00M0.00M0.01M-0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
699.00-319.00-441.00-477.00-478.00352.005.00-521.00-503.00-146.000.00M816.00-92.00-955.000.00M0.00M0.00M0.00M-946.00-0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.00M0.00M0.00M-710.00-728.000.00M0.00M0.00M0.00M0.00M361.00-662.000.00M0.00M0.01M0.00M0.00M-0.01M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-488.00-389.00-609.00345.00-855.00-572.00-101.00-458.000.00M0.00M0.00M293.00-498.000.00M0.00M0.00M0.00M0.00M377.00-0.01M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M-538.000.00M0.00M-598.00-642.00-666.000.00M136.000.00M0.00M0.00M0.00M384.000.00M0.00M0.00M-0.01M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-0.28%3.10%-0.14%3.33%0.09%6.29%20.32%23.74%6.11%11.08%1.59%2.07%-5.26%-3.09%-5.21%-5.02%-2.34%-30.11%-5.06%-5.29%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
9.01%16.00%14.91%16.35%13.72%1.79%0.89%3.13%3.91%5.64%5.68%7.05%6.63%7.12%6.23%6.35%7.20%0.15%0.72%0.82%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-12.17%-11.94%-12.38%-10.12%-9.05%-5.49%0.91%10.42%15.04%19.87%23.77%27.11%24.96%22.41%20.30%16.97%16.01%0.88%-6.78%-14.73%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-14.85%-10.59%-3.26%6.08%6.48%9.78%32.27%58.39%67.92%75.50%48.18%22.23%9.12%-4.80%-11.17%-17.34%-14.79%-38.54%-38.45%-38.62%
Operating Margin (QoQ)
0.30M0.05M-0.62M0.75M-0.22M0.05M0.16M0.06M0.02M0.04M0.03M-0.09M0.02M-2.09M2.07M0.09M-0.01M-0.22M0.17M0.04M
Operating Margin Growth (5y)
-0.28M-0.82M0.57M-0.27M-0.29M-0.06M-0.01M-0.06M0.04M0.04M-0.06M-0.07M-1.94M2.27M1.69M0.19M0.33M0.58M
Operating Margin Growth (3y)
-0.30M-0.18M-0.84M-0.10M-0.35M-0.09M2.18M1.63M0.39M0.39M0.52M0.24M-1.91M0.79M0.13M0.35M0.07M0.08M0.06M
Operating Margin Growth (1y)
1.39M0.17M-0.48M0.48M-0.05M-0.05M0.73M0.05M0.29M0.28M0.14M-0.01M0.00M-2.13M-0.09M0.09M0.06M1.93M0.02M-0.03M
Operating Income (QoQ)Op. Inc (QoQ)
-18.58%-4.57%-1.00%-3.76%-7.30%-1.62%-16.60%12.46%1.74%36.63%106.08%-2,811.84%-3.84%-6.91%1.19%239.46%-121.37%-400.81%37.79%33.77%
Operating Income Growth (5y)Op. Inc Growth (5y)
-33.99%-93.36%-17.63%-11.61%-17.77%-23.94%-17.60%-12.97%-54.02%1.71%15.52%-9.23%-53.94%-9.20%-7.83%31.52%18.22%-19.35%-8.97%-0.02%
Operating Income Growth (3y)Op. Inc Growth (3y)
-93.39%-8.10%-9.65%-10.83%-100.09%-10.11%-13.94%-7.21%-2.33%3.54%27.15%-14.07%-9.14%-9.95%-9.14%55.33%29.66%-19.70%2.92%11.54%
Operating Income Growth (1y)Op. Inc Growth (1y)
10.58%-23.58%-27.30%-29.94%-17.58%-14.26%-31.91%-11.29%-1.92%36.45%103.31%-2.64%-8.47%-83.01%-3,074.70%252.98%68.52%-47.46%7.16%-144.09%
Net Margin (QoQ)
0.30M0.05M-0.63M0.74M-0.23M0.08M0.13M0.06M0.02M0.03M0.03M-0.04M-0.02M-2.01M1.99M0.09M0.01M-0.30M0.22M0.04M
Net Margin Growth (5y)
-0.28M-0.82M0.55M-0.28M-0.26M-0.06M-0.02M-0.06M0.04M0.03M0.01M-0.06M-1.83M2.62M1.68M0.28M0.30M0.57M
Net Margin Growth (3y)
-0.30M-0.18M-0.84M-0.08M-0.35M-0.03M2.54M1.60M0.54M0.37M0.55M0.23M-1.83M0.78M0.13M0.37M-0.01M0.08M0.06M
Net Margin Growth (1y)
1.36M0.32M-0.50M0.47M-0.06M-0.03M0.73M0.05M0.29M0.25M0.14M0.04M0.00M-2.05M-0.09M0.05M0.08M1.79M0.02M-0.03M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-18.58%-3.33%-3.14%-3.46%-8.53%8.36%-29.36%11.43%6.96%29.38%103.54%-2,164.58%-113.20%-5.08%-1.22%243.33%0.00%-232.09%48.18%36.24%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-41.52%-44.73%-19.38%-12.07%-18.05%-20.31%-18.20%-17.11%-116.15%-1.42%15.43%13.37%-60.65%-5.78%-12.09%29.85%30.39%-17.45%-11.06%-0.31%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-243.00%-10.33%-21.45%3.77%-116.08%-2.42%-22.40%-2.71%-1.77%10.71%26.76%10.55%-8.77%-9.38%-8.70%55.77%53.82%-33.20%1.81%12.00%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
9.85%10.89%-34.07%-30.75%-19.67%-6.13%-33.11%-13.96%2.31%24.73%102.06%51.96%-10.09%-63.82%-4,781.76%425.03%252.45%-91.65%1.89%-143.64%
Net Income (QoQ)
-18.58%-3.33%-3.14%-3.46%-8.53%8.36%-29.36%11.43%6.96%29.38%103.54%-2,164.58%-113.20%-5.08%-1.22%243.33%-125.34%-321.27%35.88%36.24%
Net Income Growth (5y)
-41.52%-172.20%-19.38%-12.07%-18.05%-20.31%-18.20%-17.11%-116.15%-1.42%15.43%13.24%-60.65%-5.78%-12.09%29.85%14.83%-20.37%-11.06%-0.31%
Net Income Growth (3y)
-243.00%-10.33%-21.45%3.52%-116.08%-2.42%-22.40%-2.71%-1.77%0.13%26.76%10.55%-8.77%-9.38%-8.70%55.77%25.38%-24.07%1.81%12.00%
Net Income Growth (1y)
9.85%-24.69%-34.07%-30.75%-19.67%-6.13%-33.11%-13.96%2.31%24.73%102.06%51.96%-10.09%-63.82%-4,781.76%425.03%61.37%-54.88%1.89%-143.64%
Net Cash Flow (QoQ)NCF (QoQ)
-220.31%50.53%-12.84%177.47%-154.36%1,133.19%-156.06%121.70%-239.12%236.63%-53.87%-464.79%131.04%320.58%-105.73%2,415.91%-234.14%72.73%-94.98%71.13%
Net Cash Flow Growth (5y)NCF Growth (5y)
-33.19%3.68%30.10%-1.19%40.41%-50.54%17.71%-22.48%19.11%18.64%-23.83%-35.14%21.41%30.17%46.11%-81.25%-34.08%-27.70%-19.20%
Net Cash Flow Growth (3y)NCF Growth (3y)
-56.59%29.52%8.94%49.36%-27.89%48.22%-47.28%41.62%-74.18%29.80%-32.35%-46.39%31.87%65.03%49.77%55.90%-110.67%-30.98%4.96%-46.46%
Net Cash Flow Growth (1y)NCF Growth (1y)
-898.80%-292.61%-166.69%-47.97%76.49%590.97%-143.94%-31.66%-74.89%-76.87%119.03%-419.86%171.37%119.68%-127.31%273.35%-849.18%-148.58%-1,552.00%-120.59%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-110.13%-224.23%43.35%-29.50%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-124.11%
Income After Tax (QoQ)
-18.58%-3.33%-3.14%-3.46%-8.53%8.36%-29.36%11.43%6.96%29.38%103.54%-2,164.58%-113.20%-5.08%-1.22%243.33%-125.34%-321.27%35.88%36.24%
Income After Tax Growth (5y)
-41.52%-172.20%-19.38%-12.07%-18.05%-20.31%-18.20%-17.11%-116.15%-1.42%15.43%13.37%-60.65%-5.78%-12.09%29.85%14.83%-20.37%-11.06%-0.31%
Income After Tax Growth (3y)
-243.00%-10.33%-21.45%3.77%-116.08%-2.42%-22.40%-2.71%-1.77%0.13%26.76%10.55%-8.77%-9.38%-8.70%55.77%25.38%-24.07%1.81%12.00%
Income After Tax Growth (1y)
9.85%-24.69%-34.07%-30.75%-19.67%-6.13%-33.11%-13.96%2.31%24.73%102.06%51.96%-10.09%-63.82%-4,781.76%425.03%61.37%-54.88%1.89%-143.64%
Gross Profit (QoQ)
74.46%
Gross Margin (QoQ)
-622.00
Free Cash Flow (QoQ)FCF (QoQ)
32.37%-78.40%-56.97%30.32%-40.93%377.39%-147.35%18.38%-15.84%97.64%-2,786.53%-13.49%-1.04%65.89%-106.75%246.56%-216.21%36.95%-96.97%48.56%
Free Cash Flow Growth (5y)FCF Growth (5y)
-29.59%-18.53%-13.43%-22.05%100.30%-8.62%-13.25%-47.13%43.19%4.23%-4.21%-47.20%13.37%2.89%27.45%-12.85%-22.08%-43.42%-6.73%
Free Cash Flow Growth (3y)FCF Growth (3y)
-50.85%-9.40%1.02%3.17%-91.84%82.60%-18.35%-13.36%-24.93%52.36%-63.59%-21.33%-38.70%20.09%12.41%50.57%-5.24%-31.33%-3.30%11.44%
Free Cash Flow Growth (1y)FCF Growth (1y)
42.91%-139.33%-386.18%-31.96%-174.99%527.58%-28.98%-51.10%-24.20%-101.06%35.57%10.42%21.87%-1,029.13%19.13%204.44%-20.12%-122.04%-111.54%-174.24%
FCF Margin (QoQ)
0.36M-0.06M-0.90M0.99M-0.28M1.31M-1.09M0.08M0.01M0.08M-0.01M-0.08M0.03M-0.61M0.61M0.06M-0.02M-0.09M0.01M0.07M
FCF Margin Growth (5y)
-0.16M-1.03M0.43M-0.32M0.92M-0.03M-0.01M-0.09M0.05M0.05M-0.05M-0.06M-0.46M2.20M1.25M0.07M-0.31M0.48M
FCF Margin Growth (3y)
-0.15M-0.15M-1.04M-0.07M-0.39M1.13M2.10M1.18M0.17M-0.23M0.41M0.08M-0.47M1.04M0.11M0.38M-1.02M0.08M0.07M
FCF Margin Growth (1y)
1.12M-0.03M-1.32M0.39M-0.25M1.12M0.93M0.02M0.31M-0.92M0.16M0.00M0.02M-0.67M-0.05M0.09M0.05M0.56M-0.04M-0.03M
EPS (Diluted) (QoQ)
-5.13%-12.19%5.31%-3.11%-8.26%8.18%-28.64%13.52%8.67%28.39%103.42%-1,963.57%-74.00%-18.27%15.85%233.41%1.60%-233.91%49.14%37.94%
EPS (Diluted) Growth (5y)
-5.60%-33.00%-2.03%4.27%-0.78%-2.75%-1.04%-4.96%-93.31%10.16%15.24%24.29%-43.02%8.49%2.25%21.82%22.22%1.44%4.12%12.02%
EPS (Diluted) Growth (3y)
-190.07%6.06%-7.83%18.61%-94.60%12.43%-12.60%10.86%12.15%22.61%26.56%19.00%4.19%2.49%6.25%45.28%44.24%-13.43%16.75%25.46%
EPS (Diluted) Growth (1y)
38.71%34.34%-6.52%-15.14%-18.57%2.96%-31.84%-10.57%6.71%27.25%101.94%58.26%20.48%-31.34%-3,326.93%331.01%234.89%-52.74%7.68%-142.94%
EPS (Basic) (QoQ)
-5.13%-12.19%5.31%-3.11%-8.26%8.18%-28.64%13.52%8.67%28.39%103.46%-1,946.90%-74.00%-18.27%15.85%235.64%-0.07%-233.91%49.14%37.94%
EPS (Basic) Growth (5y)
-21.04%-33.00%-2.03%4.27%-0.78%-2.75%-1.04%-4.96%-93.31%10.16%15.19%24.29%-41.78%8.49%5.20%21.92%22.22%1.44%4.12%12.02%
EPS (Basic) Growth (3y)
-190.07%6.06%-2.67%18.61%-91.53%12.43%-7.00%10.86%12.15%22.61%26.57%19.00%4.19%2.49%6.25%45.56%44.24%-13.43%16.75%25.46%
EPS (Basic) Growth (1y)
38.71%34.34%-6.52%-15.14%-18.57%2.96%-31.84%-10.57%6.71%27.25%101.95%58.26%20.48%-31.34%-3,298.07%334.88%234.89%-52.74%7.68%-142.24%
EBT (QoQ)
-18.63%-3.23%-2.47%-4.08%-8.21%8.40%-28.41%11.24%6.87%31.12%105.88%-1,346.78%-116.88%-8.15%1.23%246.00%-123.96%-332.04%35.18%36.76%
EBT Margin (QoQ)
0.30M0.05M-0.62M0.74M-0.22M0.08M0.13M0.06M0.02M0.03M0.03M-0.04M-0.02M-2.04M2.02M0.09M-0.01M-0.22M0.16M0.04M
EBT Margin Growth (5y)
-0.28M-0.81M0.54M-0.27M-0.26M-0.06M-0.02M-0.06M0.04M0.03M0.01M-0.06M-1.86M2.62M1.65M0.18M0.30M0.57M
EBT Margin Growth (3y)
-0.30M-0.18M-0.84M-0.08M-0.35M-0.03M2.53M1.60M0.38M0.37M0.55M0.24M-1.86M0.78M0.13M0.35M0.05M0.07M0.06M
EBT Margin Growth (1y)
1.36M0.16M-0.49M0.47M-0.05M-0.03M0.72M0.05M0.29M0.25M0.14M0.04M0.00M-2.08M-0.08M0.05M0.06M1.88M0.02M-0.03M
EBT Growth (5y)
-41.60%-134.28%-19.28%-12.33%-18.07%-20.88%-18.16%-17.05%-128.89%-0.59%15.77%13.89%-59.60%-6.15%-11.85%29.96%15.61%-19.89%-10.84%0.09%
EBT Growth (3y)
-278.53%-10.05%-21.38%3.76%-114.36%-2.36%-21.88%-2.40%-1.51%1.18%27.22%11.48%-8.24%-9.93%-8.59%56.00%26.45%-23.34%1.79%12.29%
EBT Growth (1y)
9.69%-24.88%-33.34%-30.60%-19.13%-5.71%-32.47%-12.97%2.78%26.89%103.35%52.99%-9.49%-71.90%-2,988.44%438.24%62.63%-49.31%2.02%-142.44%
EBIT (QoQ)
-18.58%-4.57%-1.00%-3.76%-7.30%-1.62%-16.60%12.46%1.74%36.63%106.08%-2,811.84%-3.84%-6.91%1.19%239.46%-121.37%-400.81%37.79%33.77%
EBIT Margin (QoQ)
0.30M0.05M-0.62M0.75M-0.22M0.05M0.16M0.06M0.02M0.04M0.03M-0.09M0.02M-2.09M2.07M0.09M-0.01M-0.22M0.17M0.04M
EBIT Margin Growth (5y)
-0.28M-0.82M0.57M-0.27M-0.29M-0.06M-0.01M-0.06M0.04M0.04M-0.06M-0.07M-1.94M2.27M1.69M0.19M0.33M0.58M
EBIT Margin Growth (3y)
-0.30M-0.18M-0.84M-0.10M-0.35M-0.09M2.18M1.63M0.39M0.39M0.52M0.24M-1.91M0.79M0.13M0.35M0.07M0.08M0.06M
EBIT Margin Growth (1y)
1.39M0.17M-0.48M0.48M-0.05M-0.05M0.73M0.05M0.29M0.28M0.14M-0.01M0.00M-2.13M-0.09M0.09M0.06M1.93M0.02M-0.03M
EBIT Growth (5y)
-33.99%-93.36%-17.63%-11.61%-17.77%-23.94%-17.60%-12.97%-54.02%1.71%15.52%-9.23%-53.94%-9.20%-7.83%31.52%18.22%-19.35%-8.97%-0.02%
EBIT Growth (3y)
-93.39%-8.10%-9.65%-10.83%-100.09%-10.11%-13.94%-7.21%-2.33%3.54%27.15%-14.07%-9.14%-9.95%-9.14%55.33%29.66%-19.70%2.92%11.54%
EBIT Growth (1y)
10.58%-23.58%-27.30%-29.94%-17.58%-14.26%-31.91%-11.29%-1.92%36.45%103.31%-2.64%-8.47%-83.01%-3,074.70%252.98%68.52%-47.46%7.16%-144.09%
EBITDA Margin (QoQ)
0.27M0.05M-0.60M0.72M-0.22M0.05M0.15M0.06M0.02M0.04M0.02M-0.08M0.02M-1.97M1.95M0.09M-0.01M-0.22M0.16M0.04M
EBITDA Margin Growth (5y)
-0.27M-0.79M0.54M-0.27M-0.27M-0.06M-0.01M-0.06M0.04M0.03M-0.05M-0.06M-1.83M2.14M1.61M0.17M0.31M0.54M
EBITDA Margin Growth (3y)
-0.28M-0.17M-0.81M-0.09M-0.34M-0.08M2.06M1.55M0.36M0.37M0.48M0.23M-1.80M0.76M0.13M0.34M0.07M0.08M0.06M
EBITDA Margin Growth (1y)
1.33M0.15M-0.48M0.44M-0.05M-0.05M0.71M0.05M0.28M0.26M0.14M-0.01M-539.00-2.01M-0.08M0.09M0.06M1.81M0.02M-0.03M
Cash from Operations (QoQ)Cash from Ops. (QoQ)
34.51%-79.05%-59.30%32.40%-43.68%396.30%-140.62%24.17%-16.75%104.24%-1,925.81%-17.38%-3.19%67.50%-117.70%248.35%-214.88%37.18%-94.71%47.75%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-126.64%-20.03%-13.79%-24.08%124.09%-13.85%-18.03%-40.99%15.95%4.64%-4.35%-45.60%14.27%2.47%27.63%-12.96%-22.25%-42.86%-6.91%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-47.51%-11.01%0.52%3.82%-87.08%83.97%-14.54%-6.48%-17.60%29.33%-61.49%-20.66%-40.40%20.51%11.78%51.93%-6.40%-31.14%-6.98%5.51%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
44.89%-133.21%-376.09%-26.27%-177.01%558.41%-16.89%-31.13%-6.55%-98.48%31.47%-6.09%6.23%-818.71%14.30%208.31%-20.58%-133.06%-108.45%-173.42%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
85.25%127.59%186.04%119.09%-26.90%-181.75%83.24%1,023.75%-34.59%-27.38%130.72%-94.43%2,027.17%19.00%-100.52%-107.54%-8,785.33%112.37%403.91%-55.07%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-22.27%32.34%53.38%43.42%-29.77%26.75%21.08%24.23%20.34%28.80%-33.28%127.42%26.98%-15.10%-15.33%-31.18%-19.18%20.80%15.98%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
-69.02%29.86%16.85%32.77%233.21%18.39%-31.43%33.45%-6.28%-4.00%38.76%26.29%59.76%107.73%-26.34%-26.32%-57.33%31.74%119.80%-25.16%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
-178.70%-67.88%130.25%125.50%226.36%-474.49%-121.94%-7.49%-17.22%173.54%1,112.38%-93.89%98.63%225.49%-100.74%-127.58%-215.20%-88.02%11,595.53%2,588.56%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-35.87%-27.51%-42.98%55.57%-14.93%249.38%-40.29%9.24%-19.23%36.75%10.95%-35.79%17.01%59.89%-2.31%50.57%-44.88%-21.93%-54.95%-36.43%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-18.42%-21.78%-27.66%-19.68%-21.11%-1.14%-12.09%-4.32%-11.48%5.15%17.56%12.71%-10.07%16.06%23.02%43.69%24.26%12.57%-13.83%-26.58%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-18.57%-12.20%-15.30%6.04%-34.55%29.92%21.50%41.43%26.09%28.93%11.52%-14.32%4.70%36.29%63.08%61.32%39.59%-15.29%-22.89%-35.62%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
99.11%12.83%-62.48%-58.77%-45.30%163.61%176.08%93.87%84.07%-27.95%33.87%-21.31%14.00%33.28%17.36%175.19%29.63%-36.71%-70.82%-87.68%
Capital Expenditures (QoQ)Capex (QoQ)
166.42%63.45%-1.29%53.82%-7.79%145.78%77.14%25.95%11.69%-65.87%-31.22%-48.23%-76.23%186.16%-87.67%313.73%-66.11%53.15%449.32%-93.77%
Capital Expenditures Growth (5y)Capex Growth (5y)
15.64%-7.57%8.07%-3.27%-9.64%-10.30%0.05%44.24%13.02%4.29%-0.31%-15.83%56.89%-35.36%7.21%-8.50%5.57%44.34%-22.49%
Capital Expenditures Growth (3y)Capex Growth (3y)
-23.63%-14.27%-15.42%12.79%33.68%258.72%98.91%210.95%255.36%173.46%130.42%65.55%-26.03%-10.85%-55.43%-38.02%-55.60%-62.08%-44.70%-79.70%
Capital Expenditures Growth (1y)Capex Growth (1y)
220.18%598.80%500.00%561.19%128.85%244.13%517.53%405.64%512.42%-14.97%-66.98%-86.43%-97.11%-75.78%-95.66%-65.30%-50.52%-73.52%1,079.41%-82.23%
Assets (QoQ)
-6.48%-5.82%-8.77%-5.29%-9.30%32.82%-10.59%-7.51%-14.44%-0.99%-12.42%19.06%-13.51%-4.73%-8.71%24.69%-1.33%-22.52%-35.73%-17.36%
Assets Growth (5y)
10.00%9.56%9.49%10.23%9.69%14.90%9.56%6.43%1.97%3.19%3.12%10.17%-0.85%0.42%-0.94%6.08%8.80%6.26%-11.14%-23.91%
Assets Growth (3y)
16.70%17.07%18.54%22.64%4.52%19.27%15.79%17.47%16.84%21.91%0.33%-12.51%-14.76%-14.44%-14.42%-6.20%-3.53%-19.39%-27.79%-30.45%
Assets Growth (1y)
130.02%148.50%44.29%-23.90%-26.20%4.08%2.00%-0.39%-6.03%-29.95%-31.38%-11.66%-10.71%-14.08%-10.44%-6.20%7.01%-12.97%-38.73%-59.39%

Adaptimmune Therapeutics Growth Metrics API

Pull Adaptimmune Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADAPY&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY